Results 211 to 220 of about 89,882 (308)

TFE3‐Rearranged PEComa(‐Like Neoplasm) of the Chest Wall Diagnosed by Fine‐Needle Aspiration: A Case Report

Diagnostic Cytopathology, Volume 54, Issue 1, Page E1-E5, January 2026.
ABSTRACT We report a rare TFE3‐rearranged perivascular epithelioid cell tumor (PEComa) of the parasternal chest wall diagnosed preoperatively by fine‐needle aspiration (FNA) cytology. The smears and cell block showed epithelioid cells with clear to granular cytoplasm and prominent nucleoli.
Shah Dev, Matthew Miller, Tom Hu, Cindy McGrath, Roseann I. Wu   +4 more
wiley   +1 more source

Early Celiac Plexus Block in Metastatic Pancreatic Cancer: A Case Report. [PDF]

Clin Case Rep
Fardman B, Sheedy C, Raymond J.
europepmc   +1 more source

A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant

CA: A Cancer Journal for Clinicians, EarlyView.
Hetal D. Mistry, MacKenzie R. Adams, Charu Taneja, Lauren J. Massingham, Elizabeth H. Dibble, Kara L. Leonard, Jesse Hart, Galina G. Lagos, Mary Anne Fenton   +8 more
wiley   +1 more source

Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome

International Journal of Cancer, Volume 158, Issue 1, Page 243-256, 1 January 2026.
What's new? Lynch syndrome (LS) significantly increases lifetime cancer risk, necessitating innovative approaches for risk stratification. Current risk assessment methods, however, fail to integrate data from different biological systems, which may be influenced by lifestyle factors.
Minta Kärkkäinen, Tero Sievänen, Tia‐Marje Korhonen, Joonas Tuomikoski, Kirsi Pylvänäinen, Sami Äyrämö, Toni T. Seppälä, Jukka‐Pekka Mecklin, Eija K. Laakkonen, Tiina Jokela   +9 more
wiley   +1 more source

Editorial: Exploring microbial interactions in pancreatic ductal adenocarcinoma microenvironment. [PDF]

Front Oncol
Veschi S, Di Sebastiano P, Mincione G.
europepmc   +1 more source

Abdominal simultaneous 3D water T1 and T2 mapping using a free‐breathing Cartesian acquisition with spiral profile ordering

Magnetic Resonance in Medicine, Volume 95, Issue 1, Page 268-285, January 2026.
Abstract Purpose To develop a method for abdominal simultaneous 3D water T1$$ {T}_1 $$ (wT1$$ \mathrm{w}{T}_1 $$) and T2$$ {T}_2 $$ (wT2$$ \mathrm{w}{T}_2 $$) mapping with isotropic resolution using a free‐breathing Cartesian acquisition with spiral profile ordering (CASPR) at 3 T.
Jonathan Stelter, Kilian Weiss, Lisa Steinhelfer, Jakob Meineke, Weitong Zhang, Bernhard Kainz, Rickmer F. Braren, Dimitrios C. Karampinos   +7 more
wiley   +1 more source

Molecular Pathology of Pancreatic Ductal Adenocarcinoma. [PDF]

Cancers (Basel)
Shalaby A, Sadri N, Xue Y.
europepmc   +1 more source

A 5‐marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma

Histopathology, Volume 88, Issue 2, Page 402-413, January 2026.
An immunohistochemical panel that provides accurate distinction of ovarian mucinous tumours from metastatic pancreatic adenocarcinoma. Aims Metastatic pancreatic adenocarcinoma (PDAC), albeit uncommon, may involve the ovary, and distinction from primary ovarian mucinous tumours (OMT) poses a diagnostic challenge.
Astrid De Boeck, Eun Young Kang, Nicola S Meagher, Kylie L Gorringe, Cheng Han Lee, Parham Minoo, Martin Köbel   +6 more
wiley   +1 more source

Response to PD-1 inhibition in MMRd/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testing. [PDF]

J Cancer Res Clin Oncol
Pahl HL, Lassmann S, Schultheis AM, Rau S, Börries M, Duyster J, Zaiss M, Quante M, Becker H, MTB-FR Network.   +9 more
europepmc   +1 more source

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract The therapeutic landscape for renal cell carcinoma (RCC) and urinary tract cancer (UTC) has transformed dramatically, creating complexity in treatment selection and sequencing. The 2025 Advanced Urologic Cancer Consensus Conference was convened to establish evidence‐based expert consensus recommendations for optimal management.
Rana R. McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Andrea Apolo, Michael B. Atkins, Rick Bangs, Kathryn E. Beckermann, Joaquim Bellmunt, Stephanie A. Berg, Mehmet A. Bilen, David Braun, Maria I. Carlo, Jason Efstathiou, Matthew Galsky, Petros Grivas, Shilpa Gupta, Naomi Haas, A. Ari Hakimi, Hans Hammers, Daniel Y. C. Heng, Michelle Hirsch, Gopakumar Iyer, Eric Jonasch, Vadim S. Koshkin, Oleksandr Kryvenko, Bryan Lewis, Roger Li, Surena Matin, Benjamin Maughan, David F. McDermott, Bradley McGregor, Joshua Meeks, Matthew Milowsky, Robert Motzer, Andrea Necchi, Dan Petrylak, Sima Porten, Thomas Powles, Brian Rini, Brian Shuch, Arlene Siefker‐Radtke, Guru Sonpavde, S. Srikala Sridhar, Cristina Suarez, Chad Tang, Abhishek Tripathi, Michiel S. Van Der Heijden, Martin Voss, Wenxin Xu, Tian Zhang, Jonathan Rosenberg, Toni K. Choueiri   +53 more
wiley   +1 more source